Omega Healthcare Investors, Inc. (NYSE:OHI) Stake Boosted by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. lifted its stake in Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 15.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,053 shares of the real estate investment trust’s stock after acquiring an additional 8,416 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Omega Healthcare Investors were worth $2,349,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of OHI. Daiwa Securities Group Inc. increased its position in Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Omega Healthcare Investors by 328.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after buying an additional 1,274,238 shares in the last quarter. FMR LLC increased its holdings in Omega Healthcare Investors by 9.9% in the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares during the last quarter. Franklin Resources Inc. raised its position in Omega Healthcare Investors by 441.4% during the third quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock valued at $17,177,000 after acquiring an additional 350,570 shares in the last quarter. Finally, Parallax Volatility Advisers L.P. lifted its stake in Omega Healthcare Investors by 115.9% in the third quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust’s stock valued at $1,424,000 after acquiring an additional 254,471 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Performance

OHI opened at $35.68 on Friday. The company has a quick ratio of 7.07, a current ratio of 7.07 and a debt-to-equity ratio of 1.02. The stock’s 50 day moving average price is $37.45 and its two-hundred day moving average price is $39.05. The firm has a market capitalization of $10.05 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.09 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 12-month low of $29.66 and a 12-month high of $44.42.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. On average, equities analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were issued a dividend of $0.67 per share. The ex-dividend date was Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 7.51%. Omega Healthcare Investors’s payout ratio is 172.90%.

Analyst Ratings Changes

Several brokerages have recently commented on OHI. Mizuho increased their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Thursday, December 5th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Royal Bank of Canada boosted their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective on the stock in a report on Monday, December 9th. Finally, JMP Securities restated a “market perform” rating on shares of Omega Healthcare Investors in a report on Friday, February 7th. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $41.67.

Read Our Latest Research Report on Omega Healthcare Investors

About Omega Healthcare Investors

(Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Read More

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.